These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29602673)

  • 1. Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs.
    Beard R; Stucki A; Schmitt M; Py G; Grundschober C; Gee AD; Tate EW
    Bioorg Med Chem; 2018 Jul; 26(11):3039-3045. PubMed ID: 29602673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors.
    Busnelli M; Bulgheroni E; Manning M; Kleinau G; Chini B
    J Pharmacol Exp Ther; 2013 Aug; 346(2):318-27. PubMed ID: 23723434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and selective oxytocin receptor agonists without disulfide bridges.
    Adachi Y; Sakimura K; Shimizu Y; Nakayama M; Terao Y; Yano T; Asami T
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2331-2335. PubMed ID: 28438540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid peptide-small molecule oxytocin analogs are potent and selective agonists of the oxytocin receptor.
    Kablaoui N; Vanase-Frawley M; Sciabola S
    Bioorg Med Chem Lett; 2018 Feb; 28(3):415-419. PubMed ID: 29273395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of Oxytocin Analogs.
    Wiśniewski K
    Methods Mol Biol; 2019; 2001():235-271. PubMed ID: 31134574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.
    Chini B; Mouillac B; Ala Y; Balestre MN; Cotte N; Trumpp-Kallmeyer S; Hoflack J; Elands J; Hibert M; Manning M
    Adv Exp Med Biol; 1995; 395():321-8. PubMed ID: 8713982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3'-diphenylalanine--a molecular docking study.
    Slusarz MJ; Sikorska E; Slusarz R
    J Pept Sci; 2013 Feb; 19(2):118-26. PubMed ID: 23303737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides.
    Dutertre S; Croker D; Daly NL; Andersson A; Muttenthaler M; Lumsden NG; Craik DJ; Alewood PF; Guillon G; Lewis RJ
    J Biol Chem; 2008 Mar; 283(11):7100-8. PubMed ID: 18174156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY; Wo NC; Cheng LL; Manning M
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and non-selective OT receptor agonists induce different locomotor behaviors in male rats via central OT receptors and peripheral V1a receptors.
    Wolfe M; Wisniewska H; Tariga H; Ibanez G; Collins JC; Wisniewski K; Qi S; Srinivasan K; Hargrove D; Lindstrom BF
    Neuropeptides; 2018 Aug; 70():64-75. PubMed ID: 29807652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
    J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1a receptors.
    Jorgensen WT; Gulliver DW; Werry EL; Reekie T; Connor M; Kassiou M
    Eur J Med Chem; 2016 Jan; 108():730-740. PubMed ID: 26741855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide.
    Arai K; Kashiwazaki A; Fujiwara Y; Tsuchiya H; Sakai N; Shibata K; Koshimizu TA
    Eur J Pharmacol; 2015 Feb; 749():98-106. PubMed ID: 25592317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function.
    Zhong M; Navratil AM; Clay C; Sanborn BM
    Biochemistry; 2004 Mar; 43(12):3490-8. PubMed ID: 15035619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oxytocin signaling complex reveals a molecular switch for cation dependence.
    Meyerowitz JG; Robertson MJ; Barros-Álvarez X; Panova O; Nwokonko RM; Gao Y; Skiniotis G
    Nat Struct Mol Biol; 2022 Mar; 29(3):274-281. PubMed ID: 35241813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.